RETRACTED ​ARTICLE: Anticoagulant agents for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials

Abstract

The online version of this article contains the full text of the retracted article as electronic supplementary material.

The CLOCK trial, a double‐blinded randomized controlled trial: Trisodium citrate 30% and minocycline 3 mg/mL plus EDTA 30 mg/mL are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis

“…According to their meta‐analysis involving 17 randomized controlled trials, catheter malfunction episodes were significantly lower in patients whose catheter was locked with antibiotics + heparin and gentamicin + citrate (P < 0.05) in comparison with heparin locks. Furthermore, the combination antimicrobial‐citrate and citrate‐alone lock solutions showed no difference . This finding supports the use of TSC alone, as it seems to be safer in regard to microbial resistance prevention …”

“…Furthermore, the combination antimicrobial‐citrate and citrate‐alone lock solutions showed no difference . This finding supports the use of TSC alone, as it seems to be safer in regard to microbial resistance prevention …”

Analysis of complications related to dialysis catheters in cancer patients

“…Severe malfunction is characterized by the absence of blood flow in the extracorporeal system and the mild malfunction with a reversal of lines. Most catheters inserted into central veins develop fibrin clots one to several weeks after implantation and are silent at first, until they obstruct the distal part of the catheter; this clot development can be minimized by the conventional use of a heparin lock to prevent access thrombosis between hemodialysis sessions [6].…”

Comparison of high-flux hemodialysis with hemodialysis filtration in treatment of uraemic pruritus: a randomized controlled trial

“…High-flux HD (HFHD) and hemodialysis filtration (HDF) are distinguished from the fiber area and pore size [14]. HFHD is emerged to eliminate blood toxins in ESRD patients [15].…”